Exploring the Benefits of Parallel Multiplex Immunohistochemistry

Life Sciences, Laboratory Technology,
  • Wednesday, October 11, 2023

Discover an innovative webinar delving into multiplex immunohistochemistry techniques and the importance of a modular approach in designing multiplex assays. Multiplex immunofluorescent (mxIF) and multiplex immunochromogenic (mxIHC) histochemistry have become important techniques for immunohistochemistry and spatialomics research as they yield significantly greater information into the tissue as the contextual relationships between markers are conserved.

Cell IDx’s UltraPlex parallel mxIF and mxIHC technology, wherein sequential application of cocktails of primary antibodies followed by cocktails of secondary detection antibodies are applied. These cocktails are applied directly to tissue and introduce several distinct advantages, including but not limited to the use of primary antibodies from any species, a single antigen retrieval step, conservation of tissue, significantly shorter staining times, and high degrees of modularity.

Combining chromogenic or fluorescent UltraPlex in your research with image analysis software yields large amounts of data produced in less time versus other multiplex techniques.

Join this webinar to gain insights into UltraPlex multiplex immunohistochemistry and the importance of a modular approach in designing multiplex assays.


Matt Levin, Leica Biosystems

Matt Levin, BSc, R&D Manager, Leica Biosystems

Matt Levin has dedicated his professional career to answering the resonating whys in the field of protein chemistry and immunology. He is currently an R&D Manager at Cell IDx, a Leica Biosystems Company, and his team is motivated to share their laboratory results with the world to not only improve the quality of people’s lives but to also leave the world as a better place. Over the past decade, Matt and his team have dedicated their efforts to creating an improved multiplex immunohistochemistry assay.

Message Presenter

Who Should Attend?

This webinar will appeal to scientists and cancer researchers interested in advancing translational science, particularly those using chromogenic and fluorescent multiplexing technologies from pharmaceutical and biotech companies and universities in the following fields:

  • Research Scientist/Associate
  • Principal Investigator/Scientist, Senior Scientist
  • Pathologist
  • Directors of R&D or Digital Imaging
  • Lab Manager
  • Research and Development Coordinator
  • Managers in Pharmaceutical and Biotechnology Companies

What You Will Learn

Attendees will gain insights into:

  • Identify what UltraPlex Multiplex is
  • Why a modular approach is important when designing multiplex assays
  • Why signal conservation is important to assay analysis

Xtalks Partner

Leica Biosystems

Leica Biosystems (LeicaBiosystems.com) is a cancer diagnostics company and a global leader in workflow solutions. Only Leica Biosystems offers the most comprehensive portfolio that spans the entire workflow from biopsy to diagnosis. With unique expertise, we are dedicated to driving innovations that connect people across radiology, pathology, surgery and oncology. Our experts are committed to delivering Improved Quality, Integrated Solutions, and Optimized Efficiencies leading to breakthrough advances in diagnostic confidence. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture. Leica Biosystems is headquartered in Germany and operates in over 100 countries.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account